KSHV levels in patient 2. The KSHV levels in this patient demonstrated an elevated viral load at initial presentation (time 0), which declined on 4 cycles of once weekly rituximab, followed by a return of his symptoms and an increase in KSHV viral load (19 months). Once again this elevated viral load declined with rituximab therapy.